Risk factors
iRhythm Holdings (IRTC) risk factors
Item 1A of every iRhythm Holdings, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors49 risks5 new20 reworded
FDA oversight risks deepen, including field-action reporting, follow-up failures, possible warning letters, and consent decree discussions.
Filed Feb 19, 2026 - FY2024 10-K risk factors44 risks
This is an initial filing with no prior year risk comparison. The company relies almost entirely on its Zio services and is heavily exposed to Medicare and commercial reimbursement rates, FDA regulations, and intellectual property protection.
Filed Feb 20, 2025